全球數(shù)字化治療護理市場調(diào)研和分析報告（英文版）-2024年1月上傳培訓課件

DIGITAL

&TRENDSDigital

Treatment

&

Care:market

data

&

analysisMarket

InsightsreportOctober2023Table

of

ContentsOverviewAppendixSummary567Product

OverviewAuthor2930MarketDefinitionKeyTakeawaysMarket

NumbersRevenue

by

marketAverageRevenue

per

User

bymarketUsersby

market9121518192225Penetration

rateCompanyProfilesStartupAnalysisDeepDives2MARKET

INSIGHTSThis

report

is

part

ofour

Market

Insights

productGainabetterunderstandingofmarketsacross190+

geographicalentities

–

onaglobal,

regional,country,

and/orstatelevel.

Accessourdatavia

webinterface,download(XLS,

PDF,PPT),or

reports.Benefitfromour48-hourcustomerservice

guarantee.?

10

sectors:

advertising&media,consumers,countries,digital

sector,finance,health,

industrialsector,mobility,andtechnology?

1,000+

markets,

e.g.,

FinTech,Food,or

Robotics?

KPIs,

e.g.,

revenue,marketshares,prices,andvolume?

Features:Compare

countries®ions,

change

currencies,

selectvisualizations,

and/or

customize

downloads?

Usecases:

sales

planning,

investment

decision

support,resourceallocation,andportfolio

management10sectors190+geographicalentities1,000+markets400+reportsFind

out

more

on:https://www.Goto

Market

Insightscom/outlook/3CHAPTER

1OverviewDigital

Treatment

&

Care

Market

poised

for

continued

growthOverview:

SummarySummaryTheDigitalTreatment

&Caremarket

isexperiencing

significantgrowth

due

totheincreasing

adoptionof

digitaltechnologies

inthe

healthcare

industry.healthcare

products.

Fertility

andmedication

trackingappsarealsogainingpopularity

among

individuals

who

are

tryingtoconceive

or

managetheirmedication

schedules.Customer

preferences:Local

special

circumstances:Customers

seek

convenience

andaccessibility

inhealthcare,

preferring

digitalsolutions

suchasremote

health

monitoring,

onlinemedical

advice,andconvenient

medication

purchases.

Connected

biometric

sensors,

digitaltherapeutics,

onlinepharmacy

services,

and

fertility

andmedication

trackingappsarepopularascustomers

valuetheirconvenience

andease

ofuse.Thedevelopment

andadoptionof

digitaltreatment

andcare

solutionsvaryacross

countries

andregions

duetolocal

regulations,

infrastructure,

and

culturalfactors.

Stricter

regulations

or

limited

internet

connectivity

canimpactthegrowthof

themarket

and

theaccessibility

ofdigitalsolutions.Trendsinthemarket:Underlying

macroeconomic

factors:Connected

biometric

sensors

anddigital

platforms

aretransforming

healthcare,allowing

individualstomonitor

their

vitalsignsand

health

conditionsinreal-timeandprovidingvaluabledataforhealthcare

professionals.

Digitaltherapeutics,software-based

interventions

toprevent,

manage,or

treat

medical

conditions,arealsogainingpopularity.Theonline

pharmacy

market

is

experiencing

significantgrowth

ascustomers

turntoonlineplatformstopurchasemedications

andTheDigitalTreatment

&Care

market

is

growing

rapidly,driven

byfactorssuchasincreasing

healthcare

costs,agingpopulation,andprevalence

of

chronic

diseases.Digitalsolutions

offer

opportunitiestoreduce

costs,

improve

outcomes,

andenhanceefficiency.

Governments

andhealthcare

providers

are

investing

indigitaltechnologies

toaddressthese

challenges

andimprove

thequalityofcare.5Sources:Market

Insights

2023Digital

Treatment

&

Care

is

the

second

largest

market

of

Digital

HealthOverview:

Market

DefinitionMarket

definitionDefinition:therapeuticcontent

topatientstoprevent,

manage,or

treat

amedical

condition.TheDigitalTreatment

&Care

market

includesdevices

and

appsthathelp

usersmonitor

andanalyzelifestyle-related

aspects

and

improve

theiroverall

health.Itcontainstheuser

and

revenue

development

offourcategories:

Digitalcaremanagement,

Connected

Biometric

Sensors,

DigitalTherapeutics

andOnlinePharmacy.AdditionalInformation:Theuserbaseof

Digitalcare

management

covers

payingand

non-payingcustomers.

Therevenue

figuresonly

includerevenues

generated

frompaidappsoffering

premium

optionsandfromin-apppurchases;

revenues

from

appdownloads

andadvertising

revenues

are

notincluded.

Thedataonly

reflects

B2Crevenues;

B2B

and

C2Crevenues

arenotcovered.Structure:TheDigitalTreatment

&Care

market

is

dividedintofourcategories:

connectedbiometric

sensors,

digitalcare

management,

online

pharmacy,and

digitaltherapeutics.

Connected

biometric

sensors

collect

data

on

avariety

ofhealthparameters

andtransmititviaelectric

signals.

Digitalcare

management

appshelpusers

monitor,

detect,

and

analyzephysical

healthconditions.

Onlinepharmacyallows

users

topurchaseover-the-counter

medications

without

aprescription.Digitaltherapeutics

aresoftware-based

interventions

thatdeliver

evidence-based6Sources:Market

Insights

2023Digital

Treatment

&

Care

accounted

for37.15%

of

the

Digital

Health

marketrevenue

in

2023Overview:

Key

Takeaways

and

inscope

/outof

scopeKeyTakeawaysInscopeOutof

scopeRevenue

intheDigitalTreatment

&Care

market

is

projected

to

reach

US$63.25bnin2023.Thismarket

includes:Thismarket

excludes:Revenue

is

expected

toshow

anannualgrowth

rate(CAGR2023-2028)

of

12.23%,resulting

inaprojected

market

volume

of

US$112.60bn

by2028.?Contraception

andfertility

apps?Medication

checker

apps?SmartBlood

pressure

meters?SmartFever

meters?Fitnessapps?Sleeping

appsUser

penetration

will

be25.72%

in2023

and

isexpected

to

hit37.30%

by2028.Theaverage

revenue

per

user(ARPU)isexpected

toamounttoUS$32.02.?Mood

improvement

apps?Healthtracking

apps?Fitnesswearables?FitnessappsInglobalcomparison,

most

revenue

will

begenerated

intheUnitedStates(US$20,410.00m

in2023).?SmartGlucose

meters?OTC

pharmaceutical

products?Carephone/social

alarms?Motion

trackers7Sources:Market

Insights

2023CHAPTER

2Market

NumbersDigital

Treatment

&

Care

revenues

are

estimated

to

increase

at

a

CAGR(1)

of16.7%

from2017

to

2028Market

Size:

Globalrevenue

forecast

inbillionUS$112.639.65103.9494.898.429.2718.4685.906.84+16.7%(1)63.2517.6273.854.682.65

14.6316.6715.6854.3212.2355.070.601.31

13.5141.0311.0812.2841.48202284.5220280.2677.05202729.700.00

7.9369.80202625.336.1963.380.0020.624.3754.54202447.090.0041.4929.6921.77201919.14201816.2520172020202120232025DigitalCareManagementConnected

Biometric

SensorsDigitalTherapeutics9Notes:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Sources:With

revenue

of

US$

23.2

billion,

Americas

is

the

biggest

market

among

selectedregions

in

2023Market

Size:

Regional

Comparison

(1/2)revenue

forecast

inbillionUS$+9.5%(1)36.55+14.9%(1)41.31+8.5%(1)21.0723.2420.66202314.02+10.9%(1)+4.7%(1)2.7020281.611.361.082023202820232023

2028Americas202820232028EuropeAfricaAsiaAustralia&Oceania10

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023With

revenue

of

US$

20.4

billion,

the

United

States

is

the

biggest

market

amongselected

countries

in

2023Market

Size:

Regional

Comparison

(2/2)revenue

forecast

inbillionUS$+11.8%(1)35.72+18.6%(1)28.2320.4112.012023+9.4%(1)+10.1%(1)4.39+10.0%(1)4.803.062.9020282.711.8020282023202820232028202320232028ChinaUnited

StatesJapanUnited

KingdomGermany11

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Digital

Treatment

&

Care

average

revenue

per

user

is

estimated

to

increase

from2017

to

2028Market

Size:

Globalarpuforecast

inUS$105.501101009080706050403020100101.2597.0292.8888.8036.0985.0637.1382.4734.4381.6537.3176.9727.8173.5372.4168.2415.8435.4327.1335.3327.8135.3028.6635.0229.3816.03201815.97201925.31202423.28202123.15202223.95202317.50202020172025202620272028Connected

Biometric

SensorsDigitalTherapeuticsDigitalCareManagement12Sources:Market

Insights

2023Americas

has

the

biggest

value

for

Digital

Treatment

&

Care

average

revenueper

user

in

2028Market

Size:

Regional

Comparison

(1/2)arpuforecast

inUS$98.0295.091009092.0489.3183.0465.0081.6461.8077.4965.708071.5769.7965.4059.787064.2160.3963.2561.3662.2559.936053.8344.2445.2434.7744.6737.2550

44.0255.3818.6853.8218.0151.4817.4651.8617.7340302010032.3643.1914.9238.0414.0223.7336.5313.5622.4521.2120.0332.5712.819.339.9710.0110.2810.5310.50202610.4520278.267.1520195.986.43201810.39202820172020Africa2021Asia2022Europe202320242025AmericasAustralia&Oceania13Sources:Market

Insights

2023With

average

revenue

per

user

of

US$113.9,

the

United

States

is

the

biggestmarket

among

selected

countries

in

2023Market

Size:

Regional

Comparison

(2/2)arpuforecast

inUS$113.87120100806040200111.12110.9877.96109.17108.5673.64106.96107.1994.8082.8570.9567.6070.8869.1268.3965.22773.3862.8771.9260.0349.3040.3070.8656.9677.9566.5870.5562.2969.6859.1270.5648.9753.0148.5052.8155.6443.2151.3413.2949.7148.8048.3121.3048.0923.2648.4725.3627.4240.7411.8939.3011.0839.2419.3517.7816.4215.41202112.1920172018201920202022202320242025202620272028ChinaUnitedKingdomJapanGermanyUnitedStates14Sources:Market

Insights

2023Digital

Treatment

&

Care

users

are

estimated

to

increase

from

2017

to

2028Market

Size:

Globalusers

forecast

inbillion2.883.02.692.512.342.52.01.51.00.50.02.151.971.781.791.701.361.191.030.060.260.280.240.150.0220210.150.040.190.170.140.0120200.160.070.160.090.110.1720260.1720270.1320240.172028201720182019202220232025DigitalCareManagementConnected

Biometric

SensorsDigitalTherapeutics15Sources:Market

Insights

2023Asia

has

the

highest

number

of

Digital

Treatment

&

Care

users

in

2028Market

Size:

Regional

Comparison

(1/2)users

forecast

inbillion1.741.81.631.511.61.401.41.291.170.301.21.060.291.030.290.960.301.00.740.250.80.620.230.6

0.500.40.360.370.350.260.020.350.320.330.220.330.290.180.020.300.200.020.310.270.120.270.130.270.160.250.140.240.020.230.090.220.020.20.00.210.070.190.06

0.010.020.010.020.020.020.0120192017201820202021Australia&Oceania2022Africa2023Europe2024Americas2025Asia20262027202816Sources:Market

Insights

2023With

0.7

billion

users,

China

is

the

biggestmarket

among

selected

countries

in2023Market

Size:

Regional

Comparison

(2/2)users

forecast

inbillion1.11.00.90.80.70.60.50.40.30.20.10.01.030.960.890.820.750.680.610.150.590.540.060.060.420.060.340.120.060.050.320.060.060.0620280.06

0.310.050.22

0.040.290.050.030.030.270.110.050.030.050.260.060.050.040.030.030.040.030.020.040.030.020.18

0.040.050.15

0.030.150.050.120.040.040.030.0320172018201920202021202220232024United

States202520262027GermanyUnitedKingdomJapanChina17Sources:Market

Insights

2023Penetration

rate

for

Digital

Treatment

&

Care

is

especial

high

in

Switzerland

butalso

in

the

United

StatesPenetration

Rate:

Worldwide

ComparisonDigital

Treatment

&Care

penetration

rate

percountry

in2023

in%1.2.3.4.5.SwitzerlandUnitedStatesSingapore0.640.530.530.530.50UnitedKingdomAustralialowhigh

nodata18Sources:Market

Insights

2023Withings

decided

to

shift

its

focus

from

consumers

to

medical

professionals

andbusinessesCompany

Profiles:

WithingsWithingsKeyFactsProduct:

ConnectedHealth

&FitnessDevicesFunding:

US$

93.8

million(2020)Founded:

2008Employees:

250

(2020)Withings,which

was

foundedin2008,

offers

electronic

devices

to

tackle

chronicdiseases

suchasdiabetesandmanageissues

related

to

heart

health,sleep,

andweight.

Theirproduct

portfolio

includesseveral

non-invasive

health

devices

suchasanaloguewatches

capableof

detecting

cardiacarrhythmiasand

blood

pressuremonitors

to

detect

valvularheart

diseases,

amongstothers.

In

September

2020,

thecompany

launchedthe

ScanWatch,toutedastheworld’s

firstclinically

validatedhybridsmartwatch

and

capableof

detecting

atrialfibrillation

and

overnightbreathing

disturbances.Headquarters

:Issy-les-Moulineaux,FranceAvailabilityof

WithingsWithings’Digital

StrategyAfterre-purchase

of

WithingsbyéricCarreel

in2018,

thecompany

decided

toshiftitsfocusfrom

consumers

to

medical

professionals

andbusinesses.

In2019,

itlauncheditsB2B

unit,

MED

PRO,which

created

aremote

monitoring

platformaccessible

to

medical

personnel,

coaching

platforms,andhealthcare

institutions.InJanuary2021,

itcollaborated

with

Redox

integrating

electronic

health

records

(EHR)with

healthcare

productsandservices

toenablepatientstrackandmonitor

theirhealthathomes

while

theirdoctors'

access

and

interpret

patientdataviaRedox.19

Notes:Geographic

availability

includes

regionsWithings

ships

to,as

well

as

countries

serveddirectly

by

official

retailersSources:

Company

information,

Crunchbase,

Mobihealth,

Medcitynews,

Healthcare

GlobalPillPack

revolutionizes

the

pharmacy

industry

with

its

digital

platformCompany

Profiles:

PillPackPillPack

KeyFactsProduct:

Online

PharmacyFunding:

US$

118.23

million(2018)Founded:

2013ARPU:

US$

5000

(2018)PillPack,aBoston-based

onlinepharmacy,was

acquired

byAmazon

inJune2018for$750

million.

PillPack'sservices

are

designed

tomake

iteasier

forpeople

to

taketheirmedications

on

timeandasprescribed.

Thecompany

offers

severaladvantagesover

traditionalpharmacies,

including

convenience,

personalization,andaffordability.Amazon'sacquisition

of

PillPackisseen

asamajor

move

into

thehealthcare

industryand

allows

the

company

to

offer

itscustomers

awider

rangeofhealthcare

services.Headquarters

:Manchester,

NewHampshire,U.S.Availabilityof

PillPackPillPack’s

Digital

StrategyPillPack'sdigital

strategy

focuses

onproviding

aconvenient

andpersonalizedpharmacy

experience

foritscustomers.

Thecompany's

website

and

mobile

appmake

iteasy

to

manage

prescriptions,

order

refills,

and

track

shipments.

PillPack's"Insights"and

"Reminders"

features

provide

personalized

dataand

notificationstohelp

customers

improve

medication

adherence.

PillPack

isalsoactiveon

socialmedia

toshareinformation,

educate

customers,

and

provide

support.20

Notes:Geographic

availability

includes

regionsPillPack

OperatesSources:

Company

information,

American

Hospital

AssociationKaia

Health

transforms

chronic

disease

management

with

AI(1)-powered

digitaltherapiesCompany

Profiles:

KaiaHealthKaia

Health

KeyFactsFunding:

US$

101

million

(2021)Founded:

2016Product:

Digital

TherapeuticsUsers:

650000

(2023)KaiaHealth

isadigitaltherapeuticscompany

thatdevelops

evidence-basedtreatments

formusculoskeletal

disorders

(MSDs)

and

Chronic

obstructivepulmonary

disease

(COPD).KaiaHealth'splatform

usesartificialintelligence

andcomputer

vision

to

provide

patientswith

personalized

exercise

programs

and

real-timefeedback.

KaiaHealth'sprograms

havebeen

shown

tobeeffective

inreducingpain,improving

function,andreducing

the

need

forpainmedication.

Kaia

Health'sdigitaltherapy

platformoffers

several

advantagesover

traditionaltreatments

forMSDs,includingconvenience,

personalization,

and

affordability.Headquarters

:Munich,GermanyAvailabilityof

Kaia

HealthKaia

Health’sDigital

StrategyKaiaHealth

isadigitaltherapeuticscompany

withamission

toprovide

convenient,personalized,

andaffordableaccess

tohigh-quality,medical-grade

therapyprograms

forchronic

diseases.

Kaia'sAI

Labis

dedicated

to

innovation

inthedevelopment

ofdigitaltherapies

thatadapt

andrespond

tousers'

individual

needs.Kaia’sfutureportfolio

of

digital

therapies

would

includeosteoarthritis,

Parkinson'sdisease,

andother

chronic

diseases.

Kaia

envisions

adaywhen

allpatientswithchronic

illnesses

will

supportor

replace

theircare

routines

withitsdigitalsolutions.21

Notes:(1)

AI

:Artificial

Intelligence

;Geographic

availability

includes

regions

Kaia

Health

operatesSources:

Company

information,

TechCrunchTata

1mg

pioneers

the

digital

healthcare

landscape

in

IndiaStart-upAnalysis:

Tata

1mgOverviewAnalysisTata1mg

is

aleadingdigitalhealthcare

platforminIndia

thatoffers

awide

rangeof

Is

theproductunique?products

and

services,

including

medicines,

over-the-counter

drugs,healthTata1mg

is

aone-stop

shop

forallhealthcare

needs,

offering

awide

rangeofsupplements,

diagnostictests,onlinedoctor

consultations,andappointmentbooking.

Thecompany

was

foundedin2015

with

over

10

million

customers

and

isvalued

atUS$

1.3

billion.Tata1mg

partners

with

anetwork

oflicensed

andverifiedpharmacies

across

thecountry

to

offer

awide

rangeof

medicines

andhealthproducts

atcompetitive

prices.

Tata1mg

iscommitted

toproviding

itscustomerswith

ahigh-qualityexperience

and

is

atrusted

brand

intheIndian

healthcareindustry.products

and

services

atcompetitive

prices,with

theconvenience

of

onlineordering

anddelivery.

Itis

atrustedbrandwith

acommitment

to

quality.What

are

itsadvantages,

andcanit

handlepossibleconstraints?Tata1mg's

advantagesincludeitswide

rangeof

productsandservices,

competitiveprices,

convenience,

and

trustworthiness.

Itskey

challenges

includecompetitionfrom

otheronline

pharmacies

and

e-commerce

platforms,

aswell

astheneed

tomaintainhighstandards

of

qualityand

customer

service.AsIndia'sdigitalhealthcare

market

continues

to

evolve,

Tata

1mg

will

need

tofocusoninnovation

andcustomer

satisfactiontomaintainitsleadershipposition.

Adapting

Tata1mg’s

productexpansion

strategy

tooffermoreproduct

and

service

tomeet

the

growing

needs

ofIndian

consumers

couldbeakey

step

tostayaheadof

itscompetitors.22Sources:

Company

Information;

Money

Control;YourStoryFlo

offers

women’s

health

products

that

leverages

the

powerof

AI(1)-enabledneural

networksStart-upAnalysis:

FloOverviewAnalysisOriginally

foundedinBelarus,

Flois

astartupwhich

allows

women

totracknot

only

Is

theproductunique?theirperiod

cycle

but

alsotheirpregnancy

once

they

conceive.

Theapp

partnersFloispartof

the

burgeoning

female-technology

industry.Thecompany’s

mainwith

experts

anddoctors

to

offer

content

inareas

suchas

diseases,

beauty,mentalhealth,lifestyle

andprenatal

and

postnatalcare.

ItalsousesAIto

offer

customizedservices

toitsmembers.

Theapp’sannual

subscription

costsonly

US$9.99

but

in-apppurchasessuchasFloPremium

and

Pregnancy

Assistantcost

asmuch

asUS$49.99

peryear.

Flowas

founded

in2015

andbythe

beginning

of2021,

ithad38competitors

are

Clue,Glow,

and

Ovia

Health,which

offer

similarservices.

Flo’sappeal

liesinitsmedical

boardconsisting

of

60

doctors

from

EuropeandNorthAmerica.What

are

itsadvantages,

andcanithandle

possibleconstraints?million

monthlyactive

users

and165

million

downloads.

Inthefirstquarterof

2021,

Flo’s

useoftechnology

and

product

differentiation

setsitapart.ItusesAI-enabledithadraised

over

US$25

million

and

was

valued

atover

US$200

million.neural

networks

topower

itsprediction

algorithms

and

offer

more

accurateresults.Reviving

consumer

confidence

resulting

from

data

breach

allegationslevied

bytheFederal

Trade

Commission

(FTC)hasbeen

itskey

challenge.AsFemTech

gainstractionglobally,difficultiesemerge

inestablishing

theseservices

incountries

with

more

conservative

and

patriarchal

cultures,wherediscussions

aboutwomen’s

health

areconsidered

taboo.

Adapting

Flo’sproduct

expansion

strategy

tolocal

environments

andlanguagescouldbeakey

step

toovercoming

these

hurdles.23

Notes:(1)

AI

:Artificial

IntelligenceSources:

Company

Information,

TechCrunch,

The

LilyMindMaze

transforms

brain

health

with

virtual

realityStart-upAnalysis:

MindMazeOverviewAnalysisMindMaze

is

aSwiss-based

startupfoundedin2012

isdeveloping

innovative

digital

Is

theproductunique?therapeutics

and

technologies

to

improve

brainhealthandrehabilitation.MindMaze's

uniqueproductofferings

are

personalized

treatment

and

engagement.MindMaze's

flagshipproduct

isasuiteof

virtualreality

(VR)

games

and

exercisesthatare

designed

tostimulatethe

brainandpromote

neuroplasticity.

Thecompanyiscurrently

valued

atUS$1.5

billion.MindMaze

isarapidlygrowing

company

with

abrightfuture.Thecompany

iswell-positioned

to

playaleading

role

inthefutureofhealthcare.Itsproducts

aretailored

toindividual

needs

and

are

designed

tobeengagingandmotivating,ensuring

the

most

effective

treatment.What

are

itsadvantages,

andcanit

handlepossibleconstraints?MindMaze's

advantagesincludeitsfocusonpersonalized

treatment,engagement,andinnovation.Thecompany

is

alsowell-funded

and

hasastrong

team

ofexperts.MindMaze's

key

challenges

includecompetition

from

other

digital

therapeuticscompanies,

aswell

astheneed

tomaintainhigh

standardsof

quality

andcustomerservice.MindMaze

is

aleadingdigitaltherapeutics

company

with

uniqueproductofferings

and

astrong

team.

Thecompany

iswell-positioned

tocontinuetogrow

and

succeed,

butitmust

overcome

challenges

suchascompetition

andthe

need

to

maintainhighstandards.24Sources:

Company

InformationJapan

has

the

least

consumer

demand

for

Online

Pharmacy

from

selectedcountries

in

2023Deep

dives:

AttitudesTowards

OnlinePharmacy

in2023Consumerbehaviorof

medication

purchasesbycountry62%67%58%18%80%34%43%35%30%19%11%40%4%3%10%16%11%3%14%27%5%3%2%5%U.S.GermanyIndiaJapanLocal

pharmacyLocal

retail

storeOnlinepharmacyOnlinestoreOtherNot

purchased

me